Ozempic® & Semaglutide Lawsuits Are Happening Right Now

We Are Fighting For You

Maddox & Cisneros, PLLC, is actively investigating and placing claims on behalf of patients and individuals who suffered severe gastrointestinal damages and related complications after using Ozempic®, Wegovy®, Rybelsus®, Mounjaro®, Trulicity®, Jardiance®, and other semaglutide (GLP‑1) drugs.

Plaintiffs across the country and worldwide are claiming that drug manufacturers, distributors, physicians, marketers, and others failed to adequately warn people about the risks.

Additionally, whether you’re a patient or an attorney searching for co-counsel to litigate individual cases or facilitate class action,

People are suffering debilitating symptoms

Many of them long‑term, permanent, and irreparably damaging to stomachs, intestines, gallbladders, and other organs.

  • Health
  • Quality of life
  • Careers
  • Abilities
  • Relationships
  • And futures

HAVE BEEN COMPROMISED!

When you or a loved one is having serious digestive problems, vision changes, or any other complications after taking these medications, you should check with an attorney. You might be able to participate in emerging Ozempic® and GLP‑1 multidistrict litigations (MDL). That means your case and similar ones could go before one judge for more efficient pretrial proceedings. MDL consolidates discovery and motions to reduce costs, better avoid inconsistent rulings, and can often lead to settlement via representatives.

The Damages Claimants Are Alleging

Typical Ozempic® and semaglutide lawsuits usually assert that:
These are some of the core failure‑to‑warn and product liability issues asserted in current multidistrict and coordinated mass‑tort proceedings.

Common Injuries and Symptoms Linked to Semaglutide

People filing Ozempic® and semaglutide lawsuits often report a cluster of serious symptoms that surpass short‑term side effects. Should you experience any of the following symptoms, talk to us about a claim and compensation.

Gastrointestinal complications

Organ and systemic injuries

Psychological and body‑image effects

Vision and neurological concerns

If you endured weeks of vomiting, repeated ER visits, diagnostic testing such as gastric emptying studies, or were told you have gastroparesis, ileus, or intestinal obstruction after taking Ozempic® or another GLP‑1 drug, your situation matches the profile of cases attorneys are bringing now.

Do You Qualify for an Ozempic® or Semaglutide Case?

Most probably when

Maddox & Cisneros, PLLC, will evaluate your

Medical records, including imaging and GI testing

Prescription history

Healthcare timelines

The conduct of medical professionals

How injuries affect your employment, daily functioning, and quality of life

You do not need to know whether your case fits into a specific multidistrict litigation (MDL) or state‑court proceeding before calling us. We will figure that out for you and see what you would prefer. Our attorneys handle MDL filings, individual lawsuits, and referrals to appropriate jurisdictions as the litigation evolves.

Potential Damages in Ozempic® and Semaglutide Litigation

Every case is, of course, just a little different, but claimants in these lawsuits typically seek compensation for:
Maddox & Cisneros, PLLC, structures your claim with an eye toward mass‑tort and MDL so your case is positioned to benefit from global discovery, expert testimony, and any potential global or bellwether resolutions that are applicable.

DO NOT WAIT. ACT NOW.

Now is the time to act if you are a patient, a family member, or an attorney with a potential GLP‑1 injury case. When you wait too long statutes of limitation and filing deadlines waste otherwise valid claims. Cases are being filed nationwide.

You pay no legal fees until we recover for you.

Here’s what courts typically look for in allowing class action cases

Numerosity

Enough people are affected to make a class action lawsuit practical. This number might range between a few dozen up to thousands.

Commonality

Everyone’s claims are rooted in the same legal issues and facts. These issues might be about the same defective products, policies, fees, misrepresentations, or damages.

Typicality

The proposed class or group of people are representative of the same situation as the rest of the people in the group. The same kind of harm happened for the same reasons.

Adequate Representation

The plaintiffs and their lawyers for the group are able to fairly and adequately protect the interests of the entire class or group of people.

When these conditions are met, a court is more likely to “certify” the class so the case can proceed on a group basis.

Class Action Settlements

Every Class Action involves unique and specific circumstances, facts, parties, and laws. The following information is no guarantee, nor should it be taken as an indication of the outcome for your specific case. We offer this only as perspective about some of our past case outcomes.

$11,400,000

Product Defect, Hyundai Class Action involving dual-clutch transmission

$251,000,000-$338,900,00

Product Defect, Nissan Class Action involving CVT transmission

$493,000,000

Product Defect, Wisbo/Uponor, Class Action involving defective brass fittings

$98,500,000

Product Defect, Vanguard/Viega Class Action involving excessive brass corrosion

$1,230,000

Construction Defect involving 21 single-family homes

$2,100,000

Medical Malpractice involving wrongful drug administration

$275,900,000

Construction Defect involving 154 condominiums

For attorneys and healthcare professionals

Maddox & Cisneros, PLLC, welcomes attorney‑to‑attorney referrals, co‑counsel arrangements, and medical professional referrals for potential Ozempic® and semaglutide claims.

When your firm has received inquiries involving gastroparesis, intestinal obstruction, severe GI injuries, or NAION related to GLP‑1 drugs, contact us to discuss a referral or co‑counsel relationship.
We serve as MDL liaison counsel for out‑of‑state firms that prefer to maintain client contact while leveraging our litigation infrastructure.
We honor documented referral agreements consistent with applicable state rules of professional conduct.